Compounds > disperse blue 106
Page last updated: 2024-12-07

disperse blue 106

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

disperse blue 106: monoazo textile dye used on polyester blouses; no other info available 12/85 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID108061
SCHEMBL ID2360952
MeSH IDM0141027

Synonyms (41)

Synonym
ethanol, 2-(ethyl(3-methyl-4-((5-nitro-2-thiazolyl)azo)phenyl)amino)-
c.i. disperse blue 106
disperse blue 106
2-(ethyl(3-methyl-4-((5-nitro-2-thiazolyl)azo)phenyl)amino)ethanol
2-(ethyl(3-methyl-4-((5-nitrothiazol-2-yl)azo)phenyl)amino)ethanol
2-[n-ethyl-3-methyl-4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]anilino]ethanol
68516-81-4
c48o4qyd6n ,
c.i. disperse blue 357
ethanol, 2-(ethyl(3-methyl-4-(2-(5-nitro-2-thiazolyl)diazenyl)phenyl)amino)-
tersetile blue crl
unii-c48o4qyd6n
c.i. 111935
einecs 271-183-4
serisol rd 400
5-nitro-2-(2-methyl-4-(n-ethyl-n-(2-hydroxyethyl)amino)phenylazo)thiazole
disperse blue 357
ci 111935
AKOS015903857
ethanol, 2-[ethyl[3-methyl-4-[(5-nitro-2-thiazolyl)azo]phenyl]amino]-
2-(ethyl(3-methyl-4-((5-nitrothiazol-2-yl)diazenyl)phenyl)amino)ethanol
SCHEMBL2360952
2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol
W-111361
2-(ethyl-3-methyl-4-[(e)-(5-nitro-1,3-thiazol-2-yl)diazenyl]anilino)ethanol #
2-(ethyl-[3-methyl-4-(5-nitrothiazol-2-ylazo)-phenyl]-amino)-ethanol
UIHYHADQHHUIOF-WUKNDPDISA-N
12223-01-7
DTXSID80864324
FT-0716718
DB14203
disperse blue 106 100 microg/ml in acetonitrile
AS-13631
mfcd08056249
2-ethyl3-methyl-4-(5-nitrothiazol-2-yl)azophenylaminoethanol
Q27275167
ethanol, 2-[ethyl[3-methyl-4-[2-(5-nitro-2-thiazolyl)diazenyl]phenyl]amino]-
c.i.disperseblue106presscake
EN300-313165
2-[ethyl({3-methyl-4-[(1e)-2-(5-nitro-1,3-thiazol-2-yl)diazen-1-yl]phenyl})amino]ethan-1-ol
2-(ethyl(3-methyl-4-((5-nitrothiazol-2-yl)diazenyl)phenyl)amino)ethan-1-ol

Research Excerpts

Overview

summarize : Disperse Blue 106 is an acknowledged skin-sensitization hazard.

ExcerptReferenceRelevance
"Disperse Blue 106 is an acknowledged skin-sensitization hazard. "( Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.
Betts, CJ; Dearman, RJ; Kimber, I; Maibach, HI, 2005)		1.77

Dosage Studied

ExcerptRelevanceReference
" initial pH, temperature, initial dye concentration adsorbent dosage and contact time."( Removal of direct blue-106 dye from aqueous solution using new activated carbons developed from pomegranate peel: adsorption equilibrium and kinetics.
Amin, NK, 2009)		0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.90)18.7374
1990's3 (9.68)18.2507
2000's13 (41.94)29.6817
2010's10 (32.26)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.41 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index58.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies14 (38.89%)4.05%
Observational0 (0.00%)0.25%
Other21 (58.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
2-nitropropane
2-nitropropane: RN given refers to cpd with locant for nitro moiety in 2 position. 2-nitropropane : A secondary nitroalkane that is propane in which a hydrogen at position 2 has been replaced by a nitro group. Mainly used as a solvent (b.p. 120degreeC).		2.110secondary nitroalkanecarcinogenic agent;
hepatotoxic agent;
polar aprotic solvent;
xenobiotic
formaldehyde
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy		2.0610aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
diphenylpyraline
diphenylpyraline: RN given refers to parent cpd; structure. allergen : A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.. diphenylpyraline : A member of the class of piperidines that is the benzhydryl ether derivative of 1-methyl-4-hydroxypiperidine. A sedating antihistamine, it is used as the hydrochloride for the symptomatic relief of allergic conditions including rhinitis and hay fever, and in pruritic skin disorders. It is also used as the teoclate salt (piprinhydrinate) as an ingredient in compound preparations for the symptomatic relief of coughs and the common cold.		2.110piperidines;
tertiary amine		cholinergic antagonist;
H1-receptor antagonist
propane
Propane: A three carbon alkane with the formula H3CCH2CH3.		2.110alkane;
gas molecular entity		food propellant
isoprene
isoprene: used in manufacture of ''synthetic'' rubber, butyl rubber; copolymer in production of elastomers; structure. isoprene : A hemiterpene with the formula CH2=C(CH3)CH=CH2; the monomer of natural rubber and a common structure motif to the isoprenoids, a large class of other naturally occurring compounds.		2.1510alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
4-phenylenediamine
4-phenylenediamine: agent hair dye responsible for contact dermatitis; RN given refers to parent cpd. 1,4-phenylenediamine : A phenylenediamine in which the amino functions are at positions 1 and 4 of the benzene nucleus.		2.1510phenylenediamineallergen;
dye;
hapten;
reagent
disperse orange 3
4-(4-nitrophenylazo)aniline : Azobenzene substituted at the phenyl 4-positions by an amino and a nitro group.		4.1140azobenzenes;
primary arylamine		allergen;
dye
disperse blue 1
[no description available]		2.0710anthraquinone
dispersion yellow 3
Dispersion Yellow 3: used in carpet industry; river pollutant. 4-(2-hydroxy-5-methylphenylazo)acetanilide : An azo dye with a structure consisting of acetanilide substituted on the 4-position of the phenyl group with a 6-hydroxy-m-tolylazo group.		2.5120
disperse red 1
Disperse Red 1 : An azo dye with a structure consisting of nitrobenzene substituted on the 4-position of the phenyl group with a 4-[N-ethyl-N-(2-hydroxyethyl)]phenylazo group.		2.4320
disperse blue 35
disperse blue 35: not a single chemical cpd		2.0710
disperse blue 124
Disperse Blue 124: RN given refers to cpd with unknown MF. Disperse Blue 124 : A monoazo compound consisting of diazene with a 5-nitrothiazol-2-yl group attached to one nitrogen and a substituted 4-aminophenyl group attached to the other; used as a dye standard for the assay of allergy-releasing dyes in textiles.		5.441901,3-thiazoles;
monoazo compound;
tertiary amine		allergen;
dye;
hapten
melamine formaldehyde
[no description available]		2.2110
basic red 46
basic red 46: monoazoic dye used for acrylic textiles implicated in contact dermatitis		2.0610
piperidines
Piperidines: A family of hexahydropyridines.		2.110
ConditionIndicatedRelationship StrengthStudiesTrials
Allergic Contact Dermatitis
[description not available]		010.52250
Bullous Dermatoses
[description not available]		02.2510
Leg Dermatoses
A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)		02.4720
Dermatitis, Allergic Contact
A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.		05.52250
Eyelid Diseases
Diseases involving the EYELIDS.		02.1710
Itching
[description not available]		02.2110
Vulvar Diseases
Pathological processes of the VULVA.		02.2110
Pruritus
An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.		02.2110
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		02.7230
Dermatitis, Irritant
A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.		02.110
Dermatitis, Occupational
A recurrent contact dermatitis caused by substances found in the work place.		03.1150
Chronic Illness
[description not available]		02.1310
Facial Dermatoses
Skin diseases involving the FACE.		02.7230
Scalp Dermatoses
Skin diseases involving the SCALP.		02.1310
Chronic Disease
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).		02.1310
Complication, Postoperative
[description not available]		02.0710
Injuries
Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.		02.0710
Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.		02.0710
Wounds and Injuries
Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.		02.0710
Hand Dermatosis
[description not available]		02.0110
Hand Dermatoses
Skin diseases involving the HANDS.		02.0110
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.0210
Dermatitis, Eczematous
[description not available]		02.420
Eczema
A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).		02.420
IgA Vasculitis
A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.		0210
Contact Dermatitis
[description not available]		07.8840
Petechiae
Pinhead size (3 mm) skin discolorization due to hemorrhage.		01.9710
Dermatitis, Contact
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.		02.8840
Purpura
Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is		01.9710